BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
873 results:

  • 1. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
    Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
    J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of Focal Adhesion Kinase and Vinculin Expression on Migration Parameters of Normal and Tumor Epitheliocytes.
    Solomatina ES; Kovaleva AV; Tvorogova AV; Vorobjev IA; Saidova AA
    Biochemistry (Mosc); 2024 Mar; 89(3):474-486. PubMed ID: 38648767
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
    Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
    Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Knowledge, attitude, and practice of lung cancer screening and associated factors among high-risk population in Lanzhou, China: A cross-sectional study.
    Zhang T; Mao Z; Li W; Ma M; Li G; Qiao X; Wang H
    Medicine (Baltimore); 2024 Mar; 103(9):e37431. PubMed ID: 38428855
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift.
    Zhang W; Zhang Y; Ouyang WW; Fa Su S; Ma Z; Li QS; Gang Yang W; Xia Chen X; Liu J; Lu B
    Cancer Radiother; 2024 Apr; 28(2):152-158. PubMed ID: 38320903
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic significance of alveolar collapse in lung invasive adenocarcinoma and its relationship with tumor infiltrating lymphocytes.
    Shen Y; Li L; Yang Z; Wen Y; Qian L; He H
    Pathol Res Pract; 2024 Feb; 254():155149. PubMed ID: 38277751
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive functional interrogation of susceptibility loci in GWASs identified KIAA0391 as a novel oncogenic driver via regulating pyroptosis in NSCLC.
    Zhang E; Sun Q; Zhang C; Ma H; Zhang J; Ding Y; Wang G; Jin C; Jin C; Fu Y; Yan C; Zhu M; Wang C; Dai J; Jin G; Hu Z; Shen H; Ma H
    Cancer Lett; 2024 Mar; 585():216646. PubMed ID: 38262497
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biological Properties of Extracts Obtained from In Vitro Culture of
    Kowalczyk T; Sikora J; Merecz-Sadowska A; Kukula-Koch W; Synowiec E; Majda A; Juda D; Śliwiński T; Sitarek P
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256118
    [No Abstract]    [Full Text] [Related]  

  • 9. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.
    Liu R; Zhu G; Sun Y; Li M; Hu Z; Cao P; Li X; Song Z; Chen J
    Front Immunol; 2023; 14():1304529. PubMed ID: 38204755
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma.
    Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C
    Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
    Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
    J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cd95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
    Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
    Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
    Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
    Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in cancer.
    Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High Expression of fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell lung cancer.
    Hu D; Yamada H; Yoshimura K; Ohta T; Tsuchiya K; Inoue Y; Funai K; Suda T; Iwashita Y; Watanabe T; Ogawa H; Kurono N; Shinmura K; Sugimura H
    Curr Oncol; 2023 Oct; 30(11):9484-9500. PubMed ID: 37999107
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer.
    Zhong Y; Cai C; Chen T; Gui H; Deng J; Yang M; Yu B; Song Y; Wang T; Sun X; Shi J; Chen Y; Xie D; Chen C; She Y
    Nat Commun; 2023 Nov; 14(1):7513. PubMed ID: 37980411
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell lung cancer.
    Rudin CM; Liu SV; Soo RA; Lu S; Hong MH; Lee JS; Bryl M; Dumoulin DW; Rittmeyer A; Chiu CH; Ozyilkan O; Johnson M; Navarro A; Novello S; Ozawa Y; Tam SH; Patil NS; Wen X; Huang M; Hoang T; Meng R; Reck M
    J Clin Oncol; 2024 Jan; 42(3):324-335. PubMed ID: 37976444
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Karanjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell lung cancer Cells.
    Kumar G; Pandey DM; Ghosh M; Dall'Acqua S; Gupta R; Tiwari NP; Siddique UM; Vishwakrama L; Guleri SK; Lal UR; Dubey S
    Anticancer Agents Med Chem; 2024; 24(5):317-333. PubMed ID: 37936467
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.
    Liu B; Zheng X; Li J; Yao P; Guo P; Liu W; Zhao G
    BMC Cancer; 2023 Nov; 23(1):1070. PubMed ID: 37932661
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 44.